Fertility and Sterility
Volume 91, Issue 4, Supplement , Pages 1417-1419, April 2009

Reproductive medicine meets human embryonic stem cell (hESC) research: the need to adjust the regulatory framework to actual expectations and potential detrimental consequences of hESC research

  • Jose Luis Cortes
    • ,
  • Pablo Menendez, Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Pablo Menendez Ph.D., Parque Tecnologico de las Ciencias de la Salud, Centro de Investigación Biomédica, Andalusian Stem Cell Bank, Avenida del Conocimiento s/n, 18100 Granada, Spain (FAX: 34-958-894-652).

Centro de Investigación Biomédica, Andalusian Stem Cell Bank/University of Granada, Granada, Spain

Received 26 February 2008; received in revised form 9 May 2008; accepted 15 May 2008. published online 11 August 2008.

Human embryonic stem cell (hESC)-based cell therapy depends on access to surplus embryos from IVF cycles and collaborative interactions between biomedical researchers and reproductive medicine professionals. It is becoming instrumental to achieve an international consensus about the standards that should regulate the manipulation of human embryonic tissue in two distinct settings: reproductive medicine and embryonic stem cell research. Within hESC research, the regulatory framework needs to be adjusted according to the actual expectations and potential detrimental consequences of hESC research.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 J.L.C. has nothing to disclose. P.M. has nothing to disclose.

 Supported by the Consejería de Salud, Junta de Andalucía (grants reference 0029/2006 and 0030/2006), The International Jose Carreras Foundation Against Leukemia Award (EDThomas-05 to P.M.), and the Spanish Ministry of Health (FIS-PI070026 to P.M.).

PII: S0015-0282(08)01153-9

doi:10.1016/j.fertnstert.2008.05.041

Fertility and Sterility
Volume 91, Issue 4, Supplement , Pages 1417-1419, April 2009

Article Tools